DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
DaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session.
Ticker |
DVA
|
CIK | 0000927066 |
SIC | 8090 |
Sector | Services |
Industry Category | Healthcare |
Industry Group | Services – Health |
Address | 2000 16TH STREET, DENVER, CO, 80202 |
Website | davita.com |
Phone | 310-536-2668 |
CEO | Javier J. Rodriguez |
Employees | 70,000 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
Cash Flow Statement
|
Calculations
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to NoteDaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session. Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?DVA rides early momentum from phosphate binders ahead of second-quarter 2025 earnings, but PD supply issues may cloud growth. OneOncology Names Ian Wong Chief Operating OfficerOneOncology, a physician-led national platform empowering independent oncology practices, is pleased to announce that Ian Wong has been appointed Chief Operating Officer (COO). Chemed (CHE) Q2 Earnings Miss EstimatesChemed (CHE) delivered earnings and revenue surprises of -10.67% and +0.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock? DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings GrowthDaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |